Modulation of Cell Plasticity by Budesonide: Beyond the Metabolic and Anti‐Inflammatory Actions of Glucocorticoids

Abstract excerpt

The synthetic cortisol analog budesonide (BUD) is an essential drug employed to manage chronic inflammatory diseases in humans, mainly those involving gastroenteric and airway mucosa, such as rhinitis, laryngitis, bronchitis, esophagitis, gastritis, and colitis, with high levels of success. As a glucocorticoid, BUD prevents the expression of pro-inflammatory cytokines/chemokines and the recruitment of immune cells...

Topics

Open a Topic to create a Post that cites this publication.

• Asthma and respiratory diseases
• Disease Models, Animal
• Estrogen and related hormone effects
• Glucocorticoids
• Hormonal Regulation and Hypertension
• IL-33, ST2, and ILC Pathways
• Inflammation
• Models, Biological

Identifiers and source

Literature Corpus work

62a1c6b7-dc27-5eb9-aa3e-baf91837e0cb

DOI

10.20944/preprints202502.2302.v1